All VTI Articles
-
77ClinicalCurrently Available Myopia Control Soft Lenses: How Do They Compare?
September 3, 2024 By Rebecca Dang, BOptom/BSci (Hons), MOptom Soft myopia control contact lenses (CLs) present an effective intervention for progressing myopes,1...
-
521Latest Myopia NewsGelflex Named Australia and New Zealand Distributor of NaturalVue Multifocals
August 22, 2024 ATLANTA, Ga./PERTH, Australia — Visioneering Technologies Inc. (VTI) has announced Gelflex as the official distributor of its NaturalVue Multifocal...
-
1.9KClinicalTreating Myopia Progression in Teens
sponsored content July 15, 2024 By Ilana Gelfond-Polnariev, OD, FOVDR When I put my teen patients into NaturalVue Enhanced Multifocals, which are...
-
764ClinicalSurprising Results with NaturalVue Multifocals with Astigmatic Kids
sponsored content June 3, 2024 Visioneering Technologies, Inc.’s (VTI) NaturalVue Multifocal 1 day contact lenses have been shown to be safe and...
-
606Practice ProfilesTalking About Your Passions Builds Myopia Management Success
May 15, 2024 By Arthur Jung, OD I have such a passion for myopia, and that’s clear in how I communicate with...
-
1.1KLatest Myopia NewsVTI Shares Latest Data From PROTECT Study at ARVO 2024
May 6, 2024 SEATTLE, Wash. — Visioneering Technologies Inc. has shared the latest data from its PROTECT (PROgressive Myopia Treatment Evaluation for...
-
664ClinicalTalking to Parents About Myopia Gets More Pediatric Patients in My Office Chair
April 15, 2024 By Jamie Brosof, OD The first step in our office is starting the conversation about myopia management with my...
-
946PodcastsNew Data and Fitting Experience Revealed for VTI’s NaturalVue Multifocal Contact Lenses
sponsored content April 3, 2024 In this interview, Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies Inc. (VTI) sat down...
-
703Products & ServicesVTI’s Dr. Ashley Tuan Shares PROTECT Study’s One-Year Results
sponsored content March 4, 2024 In this video, Visioneering Technologies, Inc.’s Chief Medical Officer Dr. Ashley Tuan shares the one-year results of the...
-
675Latest Myopia NewsVTI Shares Ongoing Results of One-Year PROTECT Trial
January 22, 2024 LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation...
-
659ClinicalPROTECT Preliminary Trial Data Supports Safety and Efficacy of NaturalVue Multifocal 1 Day for Myopia Progression Control
sponsored content December 1, 2023 The presentation at the 2023 meeting of the American Academy of Optometry, “Seeing Is Believing: NaturalVue Multifocal...
-
480Products & ServicesDr. Ashley Tuan Discusses VTI’s PROTECT Trial
sponsored content October 17, 2023 Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Ashley Tuan, OD, PhD, Chief Medical Officer of Visioneering Technologies...
-
664Products & ServicesJuan Carlos Aragón Discusses His New CEO Role at Visioneering Technologies
sponsored content October 12, 2023 At the American Academy of Optometry’s Annual Meeting, Review of Myopia Management’s Editor-in-Chief John Sailer interviewed Dr. Juan...
-
664Latest Myopia NewsVTI Shares One-Year Data from PROTECT Trial at AAO 2023
October 12, 2023 NEW ORLEANS, La. — At the 2023 American Academy of Optometry meeting held here, Visioneering Technologies Inc. shared interim...
-
1.1KLatest Myopia NewsVTI’s NaturalVue Six-Year Data Confirmed by Three Independent Studies
September 8, 2023 CHICAGO — Visioneering Technologies Inc. completed a six-year clinical trial for its NaturalVue Multifocal (MF) contact lenses, and now,...
-
1.7KLatest Myopia NewsVTI Appoints Dr. Juan Carlos Aragón as CEO and Executive Director
ATLANTA — Visioneering Technologies, Inc. (ASX: VTI), a medical device company and producer of the NaturalVue Multifocal 1 Day Contact Lenses, announced...
-
969PodcastsUp Close With: GMAC’s Layna Mendlinger and Nitin Jain
May 15, 2023 This year’s new co-chairs of the Marketing Committee for the Global Myopia Awareness Coalition (GMAC) are Layna Mendlinger, Global...
-
3.4KClinical
Myopia Management Efficacy Comparison: OrthoK vs. Peripheral Defocus Contact Lenses
May 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Many therapies for myopia management have been studied and are currently...
-
2.2KClinicalA Pediatric Ophthalmologist’s Take on Myopia Management
April 17, 2023 By Carolyn Lederman, MD I’ve found that it’s been helpful when talking to parents about myopia management to tell...
-
1.0KPractice ProfilesMy Passion for Myopia Management Came from My Own Myopia
January 16, 2023 By Clarke Newman, OD, FAAO, FBCLA, FSLS, FNAP Being very myopic and having long axial lengths in both eyes,...
-
1.2KPractice ProfilesFull Scope Myopia Care Leaves No Myopic Child Behind
December 15, 2022 By Charissa Young, OD, FAAO, FSLS I knew when I became an optometrist that myopia management would be a...
-
1.1KLatest Myopia NewsVTI’s PROTECT Study Reaches 100% Enrollment
December 7, 2022 ATLANTA — Visioneering Technologies Inc.’s PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study has officially reached 100% participant enrollment....
-
1.9KClinicalStaying Active in the Eye Care Industry Improves My Myopia Care
November 15, 2022 By Kate McClure, OD, MS, FAAO As an eye care practitioner in a quickly evolving field, it is important...
-
1.5KLatest Myopia News
VTI’s NaturalVue Enhanced Multifocal Now Available in Canada
July 20, 2022 ATLANTA — Visioneering Technologies Inc.’s NaturalVue Enhanced Multifocal contact lenses are now available in Canada. The lenses feature the...
-
1.2KLatest Myopia NewsVTI Reaches 50% Enrollment Milestone for PROTECT Study
July 13, 2022 ATLANTA – Medical device company and producer of NaturalVue Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX:VTI) announced...
-
1.2KLatest Myopia NewsVTI’s Six-Year Clinical Trial Data Published in Clinical Ophthalmology
July 8, 2022 ATLANTA — Findings from Visioneering Technologies Inc.’s (VTI) six-year myopia management clinical trial were published in the Clinical Ophthalmology journal. The study...
-
1.6KImplementationVTI’s MyPath Education Initiative Enhanced My Myopia Practice
sponsored content June 15, 2022 By Andrew Brauer, OD The great thing about the MyPath resources is that there’s something in it...